Stocké à -20 ℃, valable pendant au moins 6 mois ; Stocké à -80 ℃, valable pendant au moins un an.
Données avancées
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Avis
Avis des clients
Application Protocols
No item-specific, tested applications or dilution factors are provided in the Product Data for SKU P746609. The following is general guidance (literature) for pLenti sgRNA workflows:
Packaging (if generating lentivirus):
Plate HEK293T cells to ~70% confluence.
Transfect transfer vector + packaging plasmids (e.g., psPAX2 and pMD2.G, or third-generation equivalents) with a lipid reagent.
Replace medium after 6–12 h; collect supernatant at 48 and 72 h; filter (0.45 µm).
Transduction of target cells:
Add viral supernatant with polybrene (2–8 µg/mL) to cells; optional spinoculation at 800–1000 × g for 60–90 min.
Change medium after 12–24 h; begin selection 48–72 h later if vector encodes resistance.
Validation:
Extract genomic DNA; PCR amplify target locus; quantify indels by TIDE/ICE or amplicon NGS.
Assess protein depletion by immunoblot; evaluate functional phenotypes.
Controls:
Non-targeting sgRNA control and a known positive-control sgRNA.
Adapt MOI, enhancers, and selection conditions to the specific cell line. For definitive, item-specific instructions, refer to the CoA/Spec Sheet or vector map if provided with your shipment.
MACROH2A2 encodes macroH2A2, a histone H2A variant bearing a large C-terminal macrodomain. MacroH2A variants are incorporated into nucleosomes and influence chromatin compaction, transcriptional regulation, and epigenetic states.
Reported roles include modulation of gene expression during differentiation and stress responses, maintenance of heterochromatin-like domains, and interaction with ADP-ribose metabolites through the macrodomain (literature).
Functional perturbation of MACROH2A2 via CRISPR can be used to explore chromatin dynamics, transcriptional networks, and epigenome organization in various cell contexts.
Use of this reagent (general context)
An sgRNA targeting MACROH2A2 enables:
Generation of knockout cell lines to study macroH2A2-dependent pathways.
CRISPRi-mediated repression to examine dose-dependent effects without permanent gene disruption.
CRISPRa-mediated upregulation (when paired appropriately) to test sufficiency of macroH2A2 in pathway regulation.
No clinical or diagnostic roles are implied. All uses are for controlled laboratory research consistent with institutional biosafety and ethical guidelines.
Buffer Applications
Classical buffer formulation (e.g., Good’s buffers) is not directly applicable to this genetic reagent. Instead, focus on nuclease-free, isotonic aqueous media suitable for plasmid stability and cell culture.
General guidance (literature/general knowledge)
DNA storage: Nuclease-free water or TE buffer (10 mM Tris–HCl, 1 mM EDTA, pH ~8.0) can improve long-term plasmid stability by chelating divalent cations that support nuclease activity.
Viral stocks: Store in serum-containing media or cryoprotectant-supplemented buffer as supplied; avoid buffer exchange unless necessary to maintain titer.
Transduction: Use appropriate culture medium for target cells; polycations (e.g., polybrene at 2–8 µg/mL) can enhance infection efficiency but may be cytotoxic to some lines—optimize empirically.
Item-specific buffer compositions or recommended formulations are not provided in the Product Data; refer to the CoA/Spec Sheet for precise details if applicable.
Green Alternatives
As a nucleic-acid-based research reagent, environmental considerations focus on packaging/reagents used in workflows rather than solvent substitution.
Replace toxic transfection reagents with biodegradable or peptide-based delivery systems when feasible.
Minimize single-use plastics by consolidating aliquots and using reusable racks/ice packs where safe.
Prefer enzyme formulations supplied at ambient or refrigerator-stable formats to reduce dry ice shipments when possible (not applicable to all viral stocks).
Use lower-toxicity decontaminants (e.g., peracetic acid solutions) where validated and permitted, instead of high-concentration bleach for routine surface decontamination.
RNP delivery: transient, no genomic integration risk, often reduced off-target persistence; may require specialized equipment and can have lower efficiency in some primary cells.
Select methods balancing biosafety, waste generation, and experimental requirements. No item-specific environmental specifications are provided for SKU P746609.
Pharmaceutical Uses
This product is designated for research use only and is not intended for human or veterinary use, diagnostics, or therapeutic applications.
General considerations (literature/general knowledge)
Nucleic-acid vectors like pLenti backbones are widely used in research-scale process development and method validation in bioproduction settings (e.g., evaluating transduction parameters in cell lines). However, research-grade materials typically do not meet GMP standards.
Any translation toward regulated applications would require GMP-grade materials, comprehensive characterization, validated removal of adventitious agents, and extensive regulatory documentation—outside the scope of this SKU.
Item-specific pharmacopeial status, excipient roles, or formulation uses are not specified for this item.
Physical Properties
Item-specific
Physical state/appearance: Not specified for this item; refer to CoA/Spec Sheet.
Concentration, buffer, additives (e.g., glycerol, cryoprotectants): Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight/formula: Not specified for this item; refer to CoA/Spec Sheet.
General properties (literature/general knowledge for lentiviral plasmids/sgRNA vectors)
Typical plasmid size: ~8–13 kb for many pLenti sgRNA backbones (literature; actual size depends on backbone and markers).
Solubility: Highly water-soluble as nucleic acid in common biological buffers (e.g., TE, PBS) when supplied as plasmid DNA; viral supernatants are aqueous.
Stability: DNA plasmids are stable at −20 to −80°C; repeated freeze–thaw can shear DNA. Lentiviral particles show optimal stability at −80°C and are sensitive to multiple freeze–thaw cycles (literature).
UV characteristics: Nucleic acids exhibit A260 maxima; typical purity ratios A260/A280 ~1.8–2.0 for DNA (literature). Not a specification for this item.
pH: Dependent on storage buffer (commonly pH 7–8 for DNA solutions; literature). Not specified for this item.
All quantitative physical parameters specific to SKU P746609 should be taken from the CoA/Spec Sheet or SDS if available.
Quality and Grades
Item-specific
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Sequencing verification, endotoxin level, sterility, titer (if viral), and backbone identity: Not specified for this item; refer to CoA/Spec Sheet.
General considerations (literature/general knowledge for CRISPR lentiviral vectors)
Plasmid-grade DNA: For transfection, high-quality, endotoxin-reduced plasmid DNA improves cell viability and viral packaging efficiency. Typical metrics include A260/280 ~1.8–2.0 and low endotoxin (e.g., <0.1 EU/µg), but these are not specifications for this item.
Sequence confirmation: sgRNA spacer and scaffold are commonly verified by Sanger sequencing using vector-specific primers. Full-backbone verification may use restriction mapping or NGS for critical applications.
Viral titering (if supplied as viral stock): Functionally measured (TU/mL) or by p24/RT assays; the acceptable range depends on application. Not specified for this item.
Stabilizers/additives: Glycerol or serum proteins may be present in viral stocks for freeze protection; presence/amount for this item is not specified.
For definitive quality attributes of SKU P746609, consult the CoA/Spec Sheet and SDS. Avoid assuming grade or titer; adjust experimental design after verifying lot-specific documentation.
Reaction and Applications
Item-specific applications (from Product Data)
Manufacturer Applications: Not specified in the Product Data.
General applications (literature/general knowledge for pLenti sgRNA constructs)
CRISPR/Cas9 genome editing: Delivery of sgRNA targeting the MACROH2A2 gene to induce indels via NHEJ when co-expressed with Cas9.
CRISPRi/CRISPRa: If paired with dCas9-KRAB or dCas9-activator systems, sgRNA can repress or activate MACROH2A2 transcription depending on target site selection.
Pooled or arrayed screening: Integration-capable lentiviral vectors enable stable sgRNA expression for loss-of-function or modulation screens in diverse cell types.
Functional genomics: Dissect roles of the macroH2A2 histone variant in chromatin organization, gene regulation, cell differentiation, and stress responses (literature background; no medical claims).
Practical notes (literature)
Target design: sgRNAs near transcription start sites for CRISPRi/a; exonic sgRNAs (early exons) for knockout. Validate off-target risk in silico.
Verification: Confirm editing by T7E1/Surveyor assays, amplicon NGS, or Sanger ICE/TIDE analysis. Validate protein impact by immunoblot or chromatin assays where relevant.
Controls: Include non-targeting and positive-control sgRNAs. Rescue experiments with sgRNA-resistant cDNAs strengthen causal inference.
Reaction Conditions
Classical chemical reaction conditions are not applicable. Below are typical conditions for workflows involving pLenti sgRNA vectors (literature/general guidance; adjust per cell line and vector system):
Transfection (HEK293T packaging): Seed cells to ~60–80% confluence; transfect transfer vector + packaging plasmids using a lipid-based reagent or PEI in serum-containing medium. Replace medium 6–12 h post-transfection. Harvest viral supernatant at 48–72 h.
Concentration: Optional PEG precipitation or ultracentrifugation to increase titer; filter through 0.45/0.22 µm as appropriate.
Transduction: Add viral supernatant to target cells with polybrene (e.g., 2–8 µg/mL) or equivalent enhancer; spinoculation may improve efficiency. Determine MOI empirically to balance efficiency and copy number.
Selection: Begin antibiotic selection 48–72 h post-transduction if the vector encodes a resistance marker; duration and concentration depend on the cell type (establish kill curve beforehand).
Editing window: Assay gene modification 3–7 days post-transduction for indels; longer for clonal isolation.
All parameters are general literature norms and are not specifications for SKU P746609. Consult the vector map/CoA for item-specific promoters, markers, and recommended conditions.
Safety and Handling
Item-specific hazard data
GHS classification, signal word, H-statements, pictograms: Not specified for this item; refer to SDS.
General safety guidance (literature/general knowledge)
Biosafety level: Handling of lentiviral packaging or transduction typically requires BSL-2 practices. Plasmid DNA without packaging is generally handled under BSL-1. Follow your institutional biosafety risk assessment and IBC approvals.
PPE: Lab coat, gloves (nitrile), and safety glasses. Use biological safety cabinet (Class II) for aerosol-generating steps with viral particles or during cell culture.
Incompatibilities: Avoid nucleases; maintain nuclease-free technique for DNA/RNA integrity. For viral supernatants, avoid exposure to disinfectants that could inactivate particles until work is complete. Decontaminate with freshly prepared 0.5–1% sodium hypochlorite or 70% ethanol as appropriate.
First aid (overview): Skin/eye contact with buffer—rinse with water. Inhalation of aerosols—move to fresh air. Ingestion—seek medical attention. Always defer to SDS and institutional medical guidance.
Waste: Deactivate lentiviral waste by chemical disinfectant (e.g., bleach, appropriate contact time) or autoclaving, per institutional policy.
Cryogenic handling: Shipments on dry ice arrive very cold; handle with thermal gloves. Avoid repeated freeze–thaw of either DNA or viral stocks; aliquot upon receipt.
Always consult the SDS, institutional biosafety program, and local regulations for authoritative safety requirements.
Solvent Selection
This product is a genetic reagent (plasmid/viral vector) rather than a small-molecule solute; conventional organic solvent selection is not typically applicable.
General guidance (literature/general knowledge)
Storage/handling media: Plasmid DNA is commonly supplied in nuclease-free water or TE buffer. Lentiviral stocks are typically in aqueous, serum-containing or serum-free media with stabilizers. Exact composition for this item is not specified.
Compatibility:
Avoid organic solvents (e.g., alcohols) that can precipitate or inactivate nucleic acids/proteins.
For cell culture applications, ensure compatibility with the target cell line’s media and antibiotics.
Filtration: 0.22 µm sterile filtration is standard for media/supernatants (do not filter pure plasmid DNA unless required, as some DNA can be lost on membranes).
For experimental workflows, focus on buffer composition, nuclease control, and cell-culture media quality rather than solvent polarity comparisons.
Storage and Reconstitution
Item-specific (from Product Data)
Storage conditions: Store at −80°C.
Shipping: Dry ice packs + cold packs.
General guidance (literature/general knowledge)
Upon receipt: Verify package integrity; record lot information; minimize time at ambient temperature. Immediately transfer to −80°C.
Aliquoting: Thaw once on ice, mix gently, and aliquot into nuclease-free tubes to avoid repeated freeze–thaw cycles. Refreeze promptly at −80°C.
Thawing: Thaw on ice; avoid >30 min at room temperature. Do not vortex lentiviral stocks vigorously; invert gently.
Reconstitution: If supplied lyophilized (not specified for this item), reconstitute with nuclease-free water or the recommended buffer to the desired concentration; allow complete dissolution on ice. For liquid formulations, no reconstitution is needed.
Short-term storage: At 4°C for ≤24–48 h may be acceptable for plasmid DNA; for viral stocks, keep on ice and use immediately for best activity (literature). Always prefer −80°C for long-term.
Record-keeping: Document freeze–thaw cycles and aliquot IDs to track performance over time.
Any buffer composition, concentration, or stabilizers specific to SKU P746609 are not specified here; refer to the CoA/Spec Sheet accompanying your lot.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
CAS, CID, InChIKey, SMILES: Not applicable/not specified for a nucleic acid construct; refer to CoA/Spec Sheet.
General description (literature/general knowledge)
pLenti-MACROH2A2-sgRNA denotes a lentiviral CRISPR vector carrying a single guide RNA (sgRNA) designed to target the MACROH2A2 gene (histone variant macroH2A2) for genome editing or transcriptional modulation (e.g., CRISPRi/a, depending on vector context).
Typical architecture of pLenti sgRNA vectors includes: 5′ and 3′ LTRs (often self-inactivating in third-generation backbones), a U6 or H1 promoter driving the sgRNA, and selection/marker cassettes (e.g., antibiotic resistance or fluorescent protein). Exact features for this item are not specified here.
2D “structure” (conceptual): A circular double-stranded DNA plasmid (if supplied as plasmid) or a packaged lentiviral genome (if supplied as viral particles). Functional domains include promoter(s), sgRNA scaffold, and lentiviral elements required for packaging and integration (vector-dependent).
Note: Exact sequence, sgRNA spacer sequence, promoter(s), selection marker, and backbone map are not provided in the Product Data; consult the CoA/Spec Sheet for definitive construct information.
Synthetic Utility
Conventional small-molecule synthetic utility does not apply. For a pLenti sgRNA construct, “utility” translates to molecular cloning and genetic engineering workflows.
General utility (literature/general knowledge)
Modular cloning: The sgRNA spacer region is typically introduced via annealed oligos using Golden Gate (e.g., BsmBI/BbsI) or Gibson assembly into the pLenti backbone.
Vector engineering: Backbones can be adapted to include different promoters, selection markers, or dual-sgRNA cassettes for multiplex editing. Homology-directed repair donors can be co-delivered from separate plasmids.
Packaging: Third-generation lentiviral systems use separate packaging plasmids (gag/pol, rev) and a VSV-G envelope plasmid for pseudotyping; the sgRNA vector provides the transfer genome. Titer and MOI optimization are key for stable integration where applicable.
Downstream verification: Colony PCR, restriction analysis, and Sanger sequencing ensure correct spacer insertion and absence of unwanted rearrangements.
Item-specific cloning sites, selection markers, and promoter elements are not provided in the Product Data and should be confirmed from the CoA/Spec Sheet or vector map.
Target Specificity
Item-specific
Intended target: MACROH2A2 gene (histone variant macroH2A2), based on the product name.
sgRNA spacer sequence, PAM context, species specificity, and predicted off-targets: Not specified for this item; refer to CoA/Spec Sheet.
General considerations (literature/general knowledge)
Species orthology: Human and mouse macroH2A2 share homology, but sgRNA efficacy is sequence-dependent; spacers are typically species-specific unless conserved target sites are used.
Off-target risk: Evaluate with in silico tools (e.g., CRISPOR, Benchling) and empirically validate by amplicon sequencing. Use high-fidelity Cas9 variants to reduce off-target cleavage where necessary.
Functional readouts: For MACROH2A2 perturbation, examine chromatin accessibility (e.g., ATAC-seq), transcriptional changes (RNA-seq), and protein levels (immunoblot) to confirm on-target impact.
Foire aux questions
How should this product be stored?
Store at ?80 °C. Ultra-low temperature storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Which species reactivity has this antibody been validated against?
Validated reactivity is listed on the PDP and on each lot's datasheet. We validate against the most commonly tested species for the target (pLenti-MACROH2A2-sgRNA); cross-reactivity in untested species may exist but is not guaranteed. Contact technical support for specific species inquiries.
Nous utilisons des cookies pour garantir le bon fonctionnement du site et, lorsque cela est autorisé, pour améliorer votre expérience. Vous pouvez gérer vos préférences à tout moment dans les Paramètres. Pour en savoir plus, consultez notre Politique relative aux cookies.
Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?
Me rappeler plus tard
Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.